Key result
A height- and weight-adjusted dose of intrathecal bupivacaine significantly reduced the incidence of hypotension during cesarean section compared to a fixed 12 mg dose (32.5% vs 60%, P=0.014).
Why the study?
Profound hypotension during cesarean section can compromise fetal circulation and cause maternal cardiac arrest, prompting evaluation of height- and weight-adjusted versus fixed-dose intrathecal bupivacaine.
Does a height- and weight-adjusted dose of intrathecal bupivacaine reduce the incidence of hypotension compared to a fixed dose in parturients undergoing elective cesarean section?
RCT (n=80)
double-blind
blind balloting
Does a height- and weight-adjusted dose of intrathecal bupivacaine reduce the incidence of hypotension compared to a fixed dose in parturients undergoing elective cesarean section?
Absolute Event Rate: 32.5% vs 60%
p-value: p=0.014
Adjusting the dose of intrathecal bupivacaine to patient height and weight significantly reduces the incidence of maternal hypotension during elective cesarean section compared to a standard fixed dose.
Adjusted dosing may reduce maternal hypotension in cesarean spinal anesthesia; leaves open whether it improves outcomes enough to change practice.
Background Profound hypotension during cesarean section can compromise fetal circulation and cause cardiac arrest in the parturients. We compared the incidence of hypotension, adequacy of anesthesia, and neonatal outcome using a height-adjusted and weight-adjusted dose and a fixed dose of 0.5% intrathecal hyperbaric bupivacaine. Patients and methods This was a randomized controlled double-blind trial involving 80 parturients aged 18–40 years scheduled for elective cesarean section under spinal anesthesia. They were randomly allocated by blind balloting into one of two groups: group FD received 12 mg of 0.5% hyperbaric bupivacaine, whereas group AD received a height-adjusted and weight-adjusted dose of 0.5% hyperbaric bupivacaine according to Harten’s chart. Parturients were preloaded with 10 ml/kg of 0.9% sodium chloride. Results The median dose of bupivacaine was significantly higher in group FD (12 mg) than group AD (9.5 mg) ( P =0.001). The incidence of hypotension was significantly higher in group FD (60%) than in group AD (32.5%) ( P =0.014). The median time to attain the maximal level of sensory block (T5) was significantly faster in group FD (10 min) than group AD (13 min) ( P =0.021). The Apgar score and incidences of other complications were comparable between both groups ( P >0.05). Conclusion It is concluded that a lower dose of bupivacaine was required to provide comparable sensory and motor block, with less incidence of hypotension when the bupivacaine dose was adjusted to the height and weight of parturients than when a fixed dose was used.
No takes yet. Share an insight, caveat, or question.
Durodola et al. (2021) conducted an RCT in elective cesarean section under spinal anesthesia (n=80). height-adjusted and weight-adjusted dose of 0.5% hyperbaric bupivacaine vs. fixed dose of 12 mg of 0.5% hyperbaric bupivacaine was evaluated on incidence of hypotension (p=0.014). A height- and weight-adjusted dose of intrathecal bupivacaine significantly reduced the incidence of hypotension during cesarean section compared to a fixed 12 mg dose (32.5% vs 60%, P=0.014).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: